Pliant Therapeutics, Inc.

US$0.81As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PLRXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (44.04%)
Div yield —
ROE (50.29%)
Biotechnology
Beta (5Y) 1.36
PE TTM —
TSR TTM (51.80%)
Mkt cap US$50.14M
ROIC (24.99%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.89
9.88%
(98.40%)
Hold 2|2|12|10|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
12.32%
2.48%
8.92%
(1.85%)
Revenue$M
3.541
3.443
3.568
3.645
17.26%
13.25%
11.31%
8.33%
Peers (US$50.14M)
Cap (US$)
PE
51.00M
—
50.25M
—
Capital
TTM
5Y
10Y
Leveragex
4.767
(0.021)
(0.019)
EBIT/Intx
0.095
2.354
2.292
Own earn%
(25.93)
39.69
33.71
Sh yield%
20.98
24.78
26.01
Owners
Insiders/Inst%
7.01
23.05
Short interest%
2.74
SBC / revenue%
1.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
1–8
$1 testx
1.0
Incr. ROIC%
91